First thalidomide clinical trial in multiple myeloma: a decade

The clinical outcomes of 169 patients enrolled in the first clinical trial of thalidomide for advanced or refractory myeloma are updated. Seventeen patients remain alive and 10 are event-free, with a median follow-up of 9.2 years. According to multivariate analysis of pretreatment variables, cytogen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van Rhee, Frits, Dhodapkar, Madhav, Shaughnessy, John D., Anaissie, Elias, Siegel, David, Hoering, Antje, Zeldis, Jerome, Jenkins, Bonnie, Singhal, Seema, Mehta, Jayesh, Crowley, John, Jagannath, Sundar, Barlogie, Bart
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515147/
https://ncbi.nlm.nih.gov/pubmed/18502827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados